Brief: Intelgenx Confirms Type A Meeting With FDA Regarding Rizaport® Versafilm®
27/05/2020 13:22
May 27 (Reuters) - Intelgenx Technologies Corp IGX.V :
* INTELGENX CONFIRMS TYPE A MEETING WITH FDA REGARDING
RIZAPORT®
VERSAFILM®
* INTELGENX TECHNOLOGIES - MEETING HAS BEEN SCHEDULED FOR
JUNE 10,
2020
Source text for Eikon: ID:nGNX6TRBNW
Further company coverage: IGX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA